These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Battipaglia G; Labopin M; Blaise D; Diez-Martin JL; Bazarbachi A; Vitek A; Chevallier P; Castagna L; Grillo G; Daguindau E; López-Jiménez J; Koc Y; Ruggeri A; Nagler A; Mohty M Transplant Cell Ther; 2022 Sep; 28(9):587.e1-587.e7. PubMed ID: 35714906 [TBL] [Abstract][Full Text] [Related]
75. Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide. McCurdy SR; Kanakry CG; Tsai HL; Gojo I; Smith BD; Gladstone DE; Bolaños-Meade J; Borrello I; Matsui WH; Swinnen LJ; Huff CA; Brodsky RA; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L Biol Blood Marrow Transplant; 2019 Jun; 25(6):1128-1135. PubMed ID: 30599208 [TBL] [Abstract][Full Text] [Related]
76. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Khan A; Tomita Y; Sykes M Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687 [TBL] [Abstract][Full Text] [Related]
77. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Gooptu M; Romee R; St Martin A; Arora M; Al Malki M; Antin JH; Bredeson CN; Brunstein CG; Chhabra S; Fuchs EJ; Ghosh N; Grunwald MR; Kanakry CG; Kekre N; McGuirk JP; McNiece IK; Mehta RS; Mielcarek M; Milano F; Modi D; Reshef R; Solomon SR; Schroeder MA; Waller EK; Inamoto Y; Soiffer RJ; Eapen M Blood; 2021 Jul; 138(3):273-282. PubMed ID: 34292325 [TBL] [Abstract][Full Text] [Related]
78. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. Ito H; Kurtz J; Shaffer J; Sykes M J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246 [TBL] [Abstract][Full Text] [Related]
79. Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide. Nishimoto M; Hirose A; Koh H; Nakamae M; Nanno S; Okamura H; Nakane T; Nakashima Y; Hino M; Nakamae H Biol Blood Marrow Transplant; 2019 Oct; 25(10):2061-2069. PubMed ID: 31195139 [TBL] [Abstract][Full Text] [Related]
80. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM; Gorechlad J; Larsen CP; Waller EK Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]